Cosmos Logo.jpg
COSMOS HOLDINGS, INC. SIGNS FOR EXCLUSIVE REPRESENTATION AGREEMENT OF COVID-19 DIAGNOSTIC DETECTION KIT FOR GERMANY, ENGLAND, GREECE & CYPRUS
April 08, 2020 15:42 ET | Cosmos Holdings Inc.
CHICAGO, April 08, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has signed a definitive agreement...
Cosmos Logo.jpg
Cosmos Holdings Engages Exchange Listing To Assist with its NASDAQ-Listing
October 16, 2019 13:42 ET | Cosmos Holdings Inc.
CHICAGO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings Inc. (OTCQB: COSM) (the “Company”) today announced it has engaged Exchange Listing LLC to assist with the planning and implementation of an...
Cosmos Logo.jpg
Cosmos Holdings, Inc. Completes $550,000 Debt-to-Equity Conversion at $7.50 Per Share
June 25, 2019 11:00 ET | Cosmos Holdings Inc.
CHICAGO, June 25, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“Cosmos” or the “Company”) (OTCQB: COSM), an international pharmaceutical company, announced today it agreed to issue 73,334 shares...
Cosmos Holdings, Inc. Completes $500,000 Debt-to-Equity Conversion at $7.50 Per Share
May 31, 2019 12:00 ET | Cosmos Holdings Inc.
CHICAGO, May 31, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“Cosmos” or the “Company”) (OTCQB: COSM), an international pharmaceutical company, announced today it agreed to issue 66,667 shares...
Cosmos Holdings, Inc. Announces Year End 2018 Financial Results
April 23, 2019 12:27 ET | Cosmos Holdings Inc.
CHICAGO, April 23, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced its full-year 2018 financial results for the year...
Cosmos Holdings, Inc. Adds to Its Advisory Board
February 20, 2019 11:47 ET | Cosmos Holdings Inc.
CHICAGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added executive Vassos Efthymiadis to...
Cosmos Holdings, Inc. Pays Off All Convertible Debt
February 06, 2019 09:00 ET | Cosmos Holdings Inc.
CHICAGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (OTCQB: COSM), an international pharmaceutical company, announced today that it paid off the remaining balance of its convertible...
Cosmos Holdings, Inc. Adds Distinguished Portfolio Manager With Mid-Cap & Large-Cap Value Expertise to Its Advisory Board
January 11, 2019 09:00 ET | Cosmos Holdings Inc.
CHICAGO, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added Tom Kolefas to its Advisory...
Cosmos Holdings acquires Cosmofarm
UPDATE -- Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.
December 21, 2018 12:38 ET | Cosmos Holdings Inc.
CHICAGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (OTCQB: COSM), an international pharmaceutical company, announced the closing of its acquisition of Cosmofarm Ltd (“Cosmofarm”), a...
Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.
December 21, 2018 09:00 ET | Cosmos Holdings Inc.
CHICAGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (OTCQB: COSM), an international pharmaceutical company, announced the closing of its acquisition of Cosmofarm Ltd (“Cosmofarm”), a...